{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:42:23Z","timestamp":1792629743606,"version":"4.5.0"},"reference-count":14,"publisher":"MyJove Corporation","issue":"152","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/60426","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T20:00:21Z","timestamp":1571860821000},"source":"Crossref","is-referenced-by-count":0,"title":["Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear\/Cytoplasmic Protein Trafficking"],"prefix":"10.3791","author":[{"given":"Jodie","family":"Hay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael  W.","family":"Moles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cassels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison  M.","family":"Michie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrc1274","type":"journal-article","article-title":"Nuclear transport and cancer: from mechanism to intervention","volume":"4","author":"Kau","year":"2004","unstructured":"Kau, T. R., Way, J. C., Silver, P. A. Nuclear transport and cancer: from mechanism to intervention. Nature Reviews Cancer. 4, 106-117, (2004).","journal-title":"Nature Reviews Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bcp.2011.12.016","type":"journal-article","article-title":"Nuclear export of proteins and drug resistance in cancer","volume":"83","author":"Turner","year":"2012","unstructured":"Turner, J. G., Dawson, J., Sullivan, D. M. Nuclear export of proteins and drug resistance in cancer. Biochemical Pharmacology. 83, 1021-1032, (2012).","journal-title":"Biochemical Pharmacology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1128\/MCB.20.23.8969-8982.2000","type":"journal-article","article-title":"Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN","volume":"20","author":"Nakamura","year":"2000","unstructured":"Nakamura, N. et al. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Molecular and Cellular Biology. 20, 8969-8982, (2000).","journal-title":"Molecular and Cellular Biology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/onc.2008.21","type":"journal-article","article-title":"The FoxO code","volume":"27","author":"Calnan","year":"2008","unstructured":"Calnan, D. R., Brunet, A. The FoxO code. Oncogene. 27, 2276-2288, (2008).","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1158\/1078-0432.CCR-18-2036","type":"journal-article","article-title":"AKT\/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival","volume":"25","author":"Cosimo","year":"2019","unstructured":"Cosimo, E. et al. AKT\/mTORC2 inhibition activates FOXO1 function in CLL cells reducing B cell receptor-mediated survival. Clinical Cancer Research. 25, 1574-1587, (2019).","journal-title":"Clinical Cancer Research"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2016.03.020","type":"journal-article","article-title":"Importins and exportins as therapeutic targets in cancer","volume":"164","author":"Mahipal","year":"2016","unstructured":"Mahipal, A., Malafa, M. Importins and exportins as therapeutic targets in cancer. Pharmacology, Therapeutics. 164, 135-143, (2016).","journal-title":"Pharmacology & Therapeutics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1038\/leu.2016.136","type":"journal-article","article-title":"Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies","volume":"30","author":"Hing","year":"2016","unstructured":"Hing, Z. A. et al. Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies. Leukemia. 30, 2364-2372, (2016).","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2012-05-429506","type":"journal-article","article-title":"Selective inhibitors of nuclear export show that CRM1\/XPO1 is a target in chronic lymphocytic leukemia","volume":"120","author":"Lapalombella","year":"2012","unstructured":"Lapalombella, R. et al. Selective inhibitors of nuclear export show that CRM1\/XPO1 is a target in chronic lymphocytic leukemia. Blood. 120, 4621-4634, (2012).","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jcp.22772","type":"journal-article","article-title":"Nuclear \u03b3-tubulin associates with nucleoli and interacts with tumor suppressor protein C53","volume":"227","author":"Ho\u0159ej\u0161\u00ed","year":"2012","unstructured":"Ho\u0159ej\u0161\u00ed, B. et al. Nuclear \u03b3-tubulin associates with nucleoli and interacts with tumor suppressor protein C53. Journal of Cellular Physiology. 227, 367-382, (2012).","journal-title":"Journal of Cellular Physiology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2141.2010.08507.x","type":"journal-article","article-title":"Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals","volume":"153","author":"McCaig","year":"2011","unstructured":"McCaig, A. M., Cosimo, E., Leach, M. T., Michie, A. M. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. British Journal of Haematology. 153, 199-211, (2011).","journal-title":"British Journal of Haematology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2017.1.338","type":"journal-article","article-title":"Optimizing frontline therapy of CLL based on clinical and biological factors","volume":"2017","author":"Fischer","year":"2017","unstructured":"Fischer, K., Hallek, M. Optimizing frontline therapy of CLL based on clinical and biological factors. Hematology. American Society of Hematology. Education Program. 2017, 338-345, (2017).","journal-title":"Hematology. American Society of Hematology. Education Program"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/ijms20092062","type":"journal-article","article-title":"Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders","volume":"20","author":"Butera","year":"2019","unstructured":"Butera, G. et al. Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders. International Journal of Molecular Sciences. 20, 2062 (2019).","journal-title":"International Journal of Molecular Sciences"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ceb.2016.12.004","type":"journal-article","article-title":"Diverse functions for different forms of nuclear actin","volume":"46","author":"Virtanen","year":"2017","unstructured":"Virtanen, J. A., Vartiainen, M. K. Diverse functions for different forms of nuclear actin. Current Opinion in Cell Biology. 46, 33-38 (2017).","journal-title":"Current Opinion in Cell Biology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0003-2697(89)90636-2","type":"journal-article","article-title":"Sensitivity and variability of the Bradford protein assay in the presence of detergents","volume":"178","author":"Friedenauer","year":"1989","unstructured":"Friedenauer, S., Berlet, H. H. Sensitivity and variability of the Bradford protein assay in the presence of detergents. Analytical Biochemistry. 178, 263-268, (1989).","journal-title":"Analytical Biochemistry"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/60426\/subcellular-fractionation-primary-chronic-lymphocytic-leukemia-cells","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:07:20Z","timestamp":1792627640000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/60426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":14,"journal-issue":{"issue":"152","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3791\/60426","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]}}}